Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Djibouti in-vivo therapeutic efficacy study 2024
PACTR202508856741773Phase 4Completed
- Sponsor
- Armauer Hansen Research Institute
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether + lumefantrine in Malaria, sponsored by Armauer Hansen Research Institute. Primary endpoint: Adequate clinical and parasitological response. Started Mar 2024; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR202508856741773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202508856741773.